Post-pandemic Era-Global Antisense and RNAi Therapeutics Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin

Report ID: 270103 | Published Date: Jan 2025 | No. of Page: 119 | Base Year: 2024 | Rating: 3.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
Table of Contents

Global Antisense and RNAi Therapeutics Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
1 Market Scope
    1.1 Product Details and Introduction
      1.1.1 RNA interference -Product Introduction and Major Manufacturers
      1.1.2 SiRNA -Product Introduction and Major Manufacturers
      1.1.3 MiRNA -Product Introduction and Major Manufacturers
      1.1.4 Antisense RNA -Product Introduction and Major Manufacturers
    1.2 Market Snapshot
      1.2.1 Major Companies Overview
      1.2.2 Market Concentration
      1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Regional Market Analysis
    2.1 China Antisense and RNAi Therapeutics Status and Prospect (2015-2026)
      2.1.1 China Antisense and RNAi Therapeutics Market Size and Growth Rate (2015-2026)
      2.1.2 China Antisense and RNAi Therapeutics Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
    2.2 EU Antisense and RNAi Therapeutics Status and Prospect (2015-2026)
      2.2.1 EU Antisense and RNAi Therapeutics Market Size and Growth Rate (2015-2026)
      2.2.2 EU Antisense and RNAi Therapeutics Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
    2.3 USA Antisense and RNAi Therapeutics Status and Prospect (2015-2026)
      2.3.1 USA Antisense and RNAi Therapeutics Market Size and Growth Rate (2015-2026)
      2.3.2 USA Antisense and RNAi Therapeutics Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
    2.4 Japan Antisense and RNAi Therapeutics Status and Prospect (2015-2026)
      2.4.1 Japan Antisense and RNAi Therapeutics Market Size and Growth Rate (2015-2026)
      2.4.2 Japan Antisense and RNAi Therapeutics Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
    2.5 India Antisense and RNAi Therapeutics Status and Prospect (2015-2026)
      2.5.1 India Antisense and RNAi Therapeutics Market Size and Growth Rate (2015-2026)
      2.5.2 India Antisense and RNAi Therapeutics Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
    2.6 Southeast Asia Antisense and RNAi Therapeutics Status and Prospect (2015-2026)
      2.6.1 Southeast Asia Antisense and RNAi Therapeutics Market Size and Growth Rate (2015-2026)
      2.6.2 Southeast Asia Antisense and RNAi Therapeutics Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
    2.7 South America Antisense and RNAi Therapeutics Status and Prospect (2015-2026)
      2.7.1 South America Antisense and RNAi Therapeutics Market Size and Growth Rate (2015-2026)
      2.7.2 South America Antisense and RNAi Therapeutics Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
    2.8  Antisense and RNAi Therapeutics Status and Prospect (2015-2026)
      2.8.1  Antisense and RNAi Therapeutics Market Size and Growth Rate (2015-2026)
      2.8.2  Antisense and RNAi Therapeutics Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
3 Global Antisense and RNAi Therapeutics Market Assessment by Segment
    3.1 Global Antisense and RNAi Therapeutics Capacity and Growth Rate
    3.2 Global Antisense and RNAi Therapeutics Sales by Type
    3.3 Global Antisense and RNAi Therapeutics Sales Revenue by Type
    3.4 Global Antisense and RNAi Therapeutics Consumption by Application
4 Global Antisense and RNAi Therapeutics Market Assessment by Regions
    4.1 Global Antisense and RNAi Therapeutics Production Analysis and Forecast by Regions (2015-2026)
    4.2 Global Antisense and RNAi Therapeutics Sales Analysis and Forecast by Regions (2015-2026)
    4.3 Global Antisense and RNAi Therapeutics Sales Revenue Analysis and Forecast by Regions (2015-2026)
5 Value Chain (Impact of COVID-19)
    5.1 Antisense and RNAi Therapeutics Value Chain Analysis
      5.1.1 Upstream
      5.1.2 Downstream
    5.2 COVID-19 Impact on Antisense and RNAi Therapeutics Industry
      5.2.1 Industrial Policy Issued Under the Epidemic Situation
    5.3 Cost-Under the Epidemic Situation
      5.3.1 Cost of Raw Material
    5.4 Channel Analysis
      5.4.1 Distribution Channel-Under the Epidemic Situation
      5.4.2 Distributors
6 Competitive Landscape
    6.1 Global Antisense and RNAi Therapeutics Capacity Market Share of Manufacturers (2019-2020)
    6.2 Global Antisense and RNAi Therapeutics Sales Market Share of Manufacturers (2019-2020)
    6.3 Global Antisense and RNAi Therapeutics Sales Revenue Market Share of Manufacturers (2019-2020)

7 Antisense and RNAi Therapeutics Competitive Analysis
     7.1 Glaxo Smith Kline
        7.1.1 Glaxo Smith Kline Company Profiles
        7.1.2 Glaxo Smith Kline Product Introduction
        7.1.3 Glaxo Smith Kline Antisense and RNAi Therapeutics Production, Revenue (2015-2020)
        7.1.4 SWOT Analysis
     7.2 Sanofi Aventis / Genzyme
        7.2.1 Sanofi Aventis / Genzyme Company Profiles
        7.2.2 Sanofi Aventis / Genzyme Product Introduction
        7.2.3 Sanofi Aventis / Genzyme Antisense and RNAi Therapeutics Production, Revenue (2015-2020)
        7.2.4 SWOT Analysis
     7.3 Isis Pharmaceuticals/ Ionis Pharmaceuticals
        7.3.1 Isis Pharmaceuticals/ Ionis Pharmaceuticals Company Profiles
        7.3.2 Isis Pharmaceuticals/ Ionis Pharmaceuticals Product Introduction
        7.3.3 Isis Pharmaceuticals/ Ionis Pharmaceuticals Antisense and RNAi Therapeutics Production, Revenue (2015-2020)
        7.3.4 SWOT Analysis
     7.4 Arbutus Biopharma Ltd.
        7.4.1 Arbutus Biopharma Ltd. Company Profiles
        7.4.2 Arbutus Biopharma Ltd. Product Introduction
        7.4.3 Arbutus Biopharma Ltd. Antisense and RNAi Therapeutics Production, Revenue (2015-2020)
        7.4.4 SWOT Analysis
     7.5 Silence Therapeutics
        7.5.1 Silence Therapeutics Company Profiles
        7.5.2 Silence Therapeutics Product Introduction
        7.5.3 Silence Therapeutics Antisense and RNAi Therapeutics Production, Revenue (2015-2020)
        7.5.4 SWOT Analysis
     7.6 Bio-Path Holdings Inc.
        7.6.1 Bio-Path Holdings Inc. Company Profiles
        7.6.2 Bio-Path Holdings Inc. Product Introduction
        7.6.3 Bio-Path Holdings Inc. Antisense and RNAi Therapeutics Production, Revenue (2015-2020)
        7.6.4 SWOT Analysis
     7.7 Calando Pharmaceuticals
        7.7.1 Calando Pharmaceuticals Company Profiles
        7.7.2 Calando Pharmaceuticals Product Introduction
        7.7.3 Calando Pharmaceuticals Antisense and RNAi Therapeutics Production, Revenue (2015-2020)
        7.7.4 SWOT Analysis
     7.8 ICo Therapeutics
        7.8.1 ICo Therapeutics Company Profiles
        7.8.2 ICo Therapeutics Product Introduction
        7.8.3 ICo Therapeutics Antisense and RNAi Therapeutics Production, Revenue (2015-2020)
        7.8.4 SWOT Analysis
     7.9 Quark Pharmaceuticals
        7.9.1 Quark Pharmaceuticals Company Profiles
        7.9.2 Quark Pharmaceuticals Product Introduction
        7.9.3 Quark Pharmaceuticals Antisense and RNAi Therapeutics Production, Revenue (2015-2020)
        7.9.4 SWOT Analysis
     7.10 Rexhan Pharmaceuticals
        7.10.1 Rexhan Pharmaceuticals Company Profiles
        7.10.2 Rexhan Pharmaceuticals Product Introduction
        7.10.3 Rexhan Pharmaceuticals Antisense and RNAi Therapeutics Production, Revenue (2015-2020)
        7.10.4 SWOT Analysis
     7.11 Biomarin/Prosensa
     7.12 Regulus Therapeutics
     7.13 Rxi Pharmaceuticals
     7.14 Silenseed
     7.15 Dicerna Pharmaceuticals
     7.16 Sirnaomics Inc
8 Conclusion



List of Tables and Figures

    Figure Product Introduction
    Table Production (K Units) and Revenue (Million USD) of Major Players (2015-2020)
    Figure Global Antisense and RNAi Therapeutics Production Market Share of Top 5 Players
    Table CAGR of Major Market (2021-2026)
    Table CAGR in Terms of Production of Each Type (2015-2026)
    Table CAGR in Terms of Production of Each Application (2015-2026)
    Table Global Antisense and RNAi Therapeutics Sales (K Unit) by Type (2015-2026)
    Figure Global Antisense and RNAi Therapeutics Sales (K Unit) and Growth Rate (2015-2026)
    Figure Global Antisense and RNAi Therapeutics Sales Market Share (%) by Type (2019 -2020)
    Table Global Antisense and RNAi Therapeutics Sales Value (Million USD) by Type (2015-2026)
    Figure Global Antisense and RNAi Therapeutics Sales Value (Million USD) and Growth Rate (2015-2026)
    Figure Global Antisense and RNAi Therapeutics Sales Value Market Share (%) by Type (2019-2020)
    Table Global Antisense and RNAi Therapeutics Sales (K Unit) by Application (2015-2026)
    Figure China Antisense and RNAi Therapeutics Production Value (Million USD) and Growth Rate (2015-2026)
    Table China Antisense and RNAi Therapeutics Local Capacity, Import, Export and Local Consumption (2015-2020)
    Figure EU Antisense and RNAi Therapeutics Production Value (Million USD) and Growth Rate (2015-2026)
    Table EU Antisense and RNAi Therapeutics Local Capacity, Import, Export and Local Consumption (2015-2020)
    Figure North America Antisense and RNAi Therapeutics Production Value (Million USD) and Growth Rate (2015-2026)
    Table North America Antisense and RNAi Therapeutics Local Capacity, Import, Export and Local Consumption (2015-2020)
    Figure Japan Antisense and RNAi Therapeutics Production Value (Million USD) and Growth Rate (2015-2026)
    Table Japan Antisense and RNAi Therapeutics Local Capacity, Import, Export and Local Consumption (2015-2020)
    Figure India Antisense and RNAi Therapeutics Production Value (Million USD) and Growth Rate (2015-2026)
    Table India Antisense and RNAi Therapeutics Local Capacity, Import, Export and Local Consumption (2015-2020)
    Figure Southeast Asia Antisense and RNAi Therapeutics Production Value (Million USD) and Growth Rate (2015-2026)
    Table Southeast Asia Antisense and RNAi Therapeutics Local Capacity, Import, Export and Local Consumption (2015-2020)
    Figure South America Antisense and RNAi Therapeutics Production Value (Million USD) and Growth Rate (2015-2026)
    Table South America Antisense and RNAi Therapeutics Local Capacity, Import, Export and Local Consumption (2015-2020)
    Figure Middle East and Africa Antisense and RNAi Therapeutics Production Value (Million USD) and Growth Rate (2015-2026)
    Table Middle East and Africa Antisense and RNAi Therapeutics Local Capacity, Import, Export and Local Consumption (2015-2020)
    Table Global Antisense and RNAi Therapeutics Capacity (K Units) and Growth Rate (2015-2026)
    Figure Global Antisense and RNAi Therapeutics Capacity (K Units) and Growth Rate (2015-2026)
    Table Global Antisense and RNAi Therapeutics Sales (Unit) by Type (2015-2026)
    Figure Global Antisense and RNAi Therapeutics Sales(Unit) and Growth Rate (2015-2026)
    Table Sales Market Share (%) by Type (2019-2026)
    Table Global Antisense and RNAi Therapeutics Sales Revenue (Million USD) by Type (2015-2026)
    Figure Global Antisense and RNAi Therapeutics Sales Revenue (Million USD) and Growth Rate (2015-2026)
    Table Sales Revenue Market Share (%) by Type (2019-2026)
    Table Global Antisense and RNAi Therapeutics Consumption (Unit) by Application (2015-2026)
    Figure Global Antisense and RNAi Therapeutics Consumption (Unit) and Growth Rate (2015-2026)
    Table Consumption Market Share (%) by Application (2019-2026)
    Table Global Antisense and RNAi Therapeutics Production (K Unite) by Regions (2015-2020)
    Table Global Antisense and RNAi Therapeutics CAGR (%) in term of Production and Market Share by Regions (2015-2026)
    Figure Global Antisense and RNAi Therapeutics Production Share by Regions (2019-2020)
    Table Global Antisense and RNAi Therapeutics Sales (K Unite) by Regions (2015-2020)
    Table Global Antisense and RNAi Therapeutics CAGR (%) in term of Sales and Market Share by Regions (2015-2026)
    Figure Global Antisense and RNAi Therapeutics Sales Share by Regions (2019-2020)
    Table Global Antisense and RNAi Therapeutics Sales Revenue (Million USD) by Regions (2015-2020)
    Table Global Antisense and RNAi Therapeutics CAGR (%) in term of Sales Revenue and Market Share by Regions (2015-2026)
    Figure Global Antisense and RNAi Therapeutics Sales Revenue Share by Regions (2019-2020)
    Figure Value Chain Structure of Antisense and RNAi Therapeutics
    Table Value Chain
    Table Key Suppliers of Raw Material/Components
    Table Key Downstream Customer in Each Application Field
    Table Industry News List of Antisense and RNAi Therapeutics
    Figure Cost Structure of Antisense and RNAi Therapeutics in 2020
    Table Global Antisense and RNAi Therapeutics Capacity Share of Manufacturers (2019-2020)
    Figure Global Antisense and RNAi Therapeutics Capacity Share of Manufacturers (2019-2020)
    Table Global Antisense and RNAi Therapeutics Sales Market Share of Manufacturers (2019-2020)
    Figure Global Antisense and RNAi Therapeutics Sales Market Share of Manufacturers (2019-2020)
    Table Global Antisense and RNAi Therapeutics Sales Revenue Market Share of Manufacturers (2019-2020)
    Figure Global Antisense and RNAi Therapeutics Sales Revenue Market Share of Manufacturers (2019-2020)
    Figure Global Antisense and RNAi Therapeutics Sales Value (Million USD), Growth Rate & Market Share (2021-2026)
    Table Glaxo Smith Kline Profiles
    Table Glaxo Smith Kline Antisense and RNAi Therapeutics Product Introduction
    Table Glaxo Smith Kline Antisense and RNAi Therapeutics Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
    Figure Glaxo Smith Kline SWOT Analysis
    Table Sanofi Aventis / Genzyme Profiles
    Table Sanofi Aventis / Genzyme Antisense and RNAi Therapeutics Product Introduction
    Table Sanofi Aventis / Genzyme Antisense and RNAi Therapeutics Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
    Figure Sanofi Aventis / Genzyme SWOT Analysis
    Table Isis Pharmaceuticals/ Ionis Pharmaceuticals Profiles
    Table Isis Pharmaceuticals/ Ionis Pharmaceuticals Antisense and RNAi Therapeutics Product Introduction
    Table Isis Pharmaceuticals/ Ionis Pharmaceuticals Antisense and RNAi Therapeutics Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
    Figure Isis Pharmaceuticals/ Ionis Pharmaceuticals SWOT Analysis
    Table Arbutus Biopharma Ltd. Profiles
    Table Arbutus Biopharma Ltd. Antisense and RNAi Therapeutics Product Introduction
    Table Arbutus Biopharma Ltd. Antisense and RNAi Therapeutics Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
    Figure Arbutus Biopharma Ltd. SWOT Analysis
    Table Silence Therapeutics Profiles
    Table Silence Therapeutics Antisense and RNAi Therapeutics Product Introduction
    Table Silence Therapeutics Antisense and RNAi Therapeutics Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
    Figure Silence Therapeutics SWOT Analysis
    Table Bio-Path Holdings Inc. Profiles
    Table Bio-Path Holdings Inc. Antisense and RNAi Therapeutics Product Introduction
    Table Bio-Path Holdings Inc. Antisense and RNAi Therapeutics Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
    Figure Bio-Path Holdings Inc. SWOT Analysis
    Table Calando Pharmaceuticals Profiles
    Table Calando Pharmaceuticals Antisense and RNAi Therapeutics Product Introduction
    Table Calando Pharmaceuticals Antisense and RNAi Therapeutics Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
    Figure Calando Pharmaceuticals SWOT Analysis
    Table ICo Therapeutics Profiles
    Table ICo Therapeutics Antisense and RNAi Therapeutics Product Introduction
    Table ICo Therapeutics Antisense and RNAi Therapeutics Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
    Figure ICo Therapeutics SWOT Analysis
    Table Quark Pharmaceuticals Profiles
    Table Quark Pharmaceuticals Antisense and RNAi Therapeutics Product Introduction
    Table Quark Pharmaceuticals Antisense and RNAi Therapeutics Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
    Figure Quark Pharmaceuticals SWOT Analysis
    Table Rexhan Pharmaceuticals Profiles
    Table Rexhan Pharmaceuticals Antisense and RNAi Therapeutics Product Introduction
    Table Rexhan Pharmaceuticals Antisense and RNAi Therapeutics Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
    Figure Rexhan Pharmaceuticals SWOT Analysis
    Table Biomarin/Prosensa Profiles
    Table Biomarin/Prosensa Antisense and RNAi Therapeutics Product Introduction
    Table Biomarin/Prosensa Antisense and RNAi Therapeutics Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
    Figure Biomarin/Prosensa SWOT Analysis
    Table Regulus Therapeutics Profiles
    Table Regulus Therapeutics Antisense and RNAi Therapeutics Product Introduction
    Table Regulus Therapeutics Antisense and RNAi Therapeutics Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
    Figure Regulus Therapeutics SWOT Analysis
    Table Rxi Pharmaceuticals Profiles
    Table Rxi Pharmaceuticals Antisense and RNAi Therapeutics Product Introduction
    Table Rxi Pharmaceuticals Antisense and RNAi Therapeutics Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
    Figure Rxi Pharmaceuticals SWOT Analysis
    Table Silenseed Profiles
    Table Silenseed Antisense and RNAi Therapeutics Product Introduction
    Table Silenseed Antisense and RNAi Therapeutics Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
    Figure Silenseed SWOT Analysis
    Table Dicerna Pharmaceuticals Profiles
    Table Dicerna Pharmaceuticals Antisense and RNAi Therapeutics Product Introduction
    Table Dicerna Pharmaceuticals Antisense and RNAi Therapeutics Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
    Figure Dicerna Pharmaceuticals SWOT Analysis
    Table Sirnaomics Inc Profiles
    Table Sirnaomics Inc Antisense and RNAi Therapeutics Product Introduction
    Table Sirnaomics Inc Antisense and RNAi Therapeutics Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
    Figure Sirnaomics Inc SWOT Analysis
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Post-pandemic Era-Global Antisense and RNAi Therapeutics Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Post-pandemic Era-Global Antisense and RNAi Therapeutics Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Post-pandemic Era-Global Antisense and RNAi Therapeutics Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports